Figure 3.
Progression-free survival (A) and progression-free survival in second line. (B) According to treatment arm (Kaplan–Meier estimation); intent to treat population. LV5FU2-CDDP arm: 5-fluorouracil, folinic acid and cisplatin combination followed by gemcitabine. Gemcitabine arm: gemcitabine followed by LV5FU2-CDDP.
